{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:26:30Z","timestamp":1779114390462,"version":"3.51.4"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9,5]]},"DOI":"10.4103\/0366-6999.239306","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T13:38:23Z","timestamp":1534513103000},"page":"2017-2024","source":"Crossref","is-referenced-by-count":22,"title":["Impact of Baseline Bleeding Risk on Efficacy and Safety of Ticagrelor versus Clopidogrel in Chinese Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention"],"prefix":"10.1097","volume":"131","author":[{"given":"He-Yang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Ling","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210129","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS guidelines on myocardial revascularization: The task force on myocardial revascularization of the European Society Of Cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS) Developed with the special contribution of the European association of percutaneous cardiovascular interventions (EAPCI)","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"R2-1-20210129","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jacc.2015.10.005","article-title":"2015 ACC\/AHA\/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: An update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction","volume":"67","author":"Levine","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R3-1-20210129","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"R4-1-20210129","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/CIRCULATIONAHA.109.927582","article-title":"Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet inhibition and patient outcomes (PLATO) trial subgroup analysis","volume":"122","author":"Steg","year":"2010","journal-title":"Circulation"},{"key":"R5-1-20210129","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1093\/eurheartj\/ehw284","article-title":"Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: Experiences from SWEDEHEART registry","volume":"37","author":"Sahl\u00e9n","year":"2016","journal-title":"Eur Heart J"},{"key":"R6-1-20210129","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1253\/circj.CJ-15-0112","article-title":"Ticagrelor vs. Clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome \u2013 Randomized, double-blind, phase III PHILO study","volume":"79","author":"Goto","year":"2015","journal-title":"Circ J"},{"key":"R7-1-20210129","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2217\/cer-2017-0074","article-title":"Ticagrelor versus clopidogrel in East-Asian patients with acute coronary syndromes: A meta-analysis of randomized trials","volume":"7","author":"Wu","year":"2018","journal-title":"J Comp Eff Res"},{"key":"R8-1-20210129","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1253\/circj.CJ-17-0632","article-title":"Cardiovascular and bleeding risks in acute myocardial infarction newly treated with ticagrelor vs. Clopidogrel in Taiwan","volume":"82","author":"Lee","year":"2018","journal-title":"Circ J"},{"key":"R9-1-20210129","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jcma.2016.02.010","article-title":"Efficacy and safety of ticagrelor versus clopidogrel in acute coronary syndrome in Taiwan: A multicenter retrospective pilot study","volume":"79","author":"Chen","year":"2016","journal-title":"J Chin Med Assoc"},{"key":"R10-1-20210129","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4244\/EIJV3I3A71","article-title":"Prognostic impact of major bleeding in patients with acute coronary syndromes. A systematic review and meta-analysis","volume":"3","author":"Hamon","year":"2007","journal-title":"EuroIntervention"},{"key":"R11-1-20210129","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.amjcard.2017.07.076","article-title":"Prognostic impact of in-hospital-bleeding in patients with ST-elevation myocardial infarction treated by primary percutaneous coronary intervention","volume":"120","author":"Cornara","year":"2017","journal-title":"Am J Cardiol"},{"key":"R12-1-20210129","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrcardio.2014.104","article-title":"Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI","volume":"11","author":"Levine","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"R13-1-20210129","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ahj.2015.03.015","article-title":"Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the platelet inhibition and patient outcomes (PLATO) trial","volume":"169","author":"Kang","year":"2015","journal-title":"Am Heart J"},{"key":"R14-1-20210129","doi-asserted-by":"crossref","first-page":"F19","DOI":"10.1093\/eurheartj\/suw034","article-title":"Switching between ticagrelor and clopidogrel in patients who underwent percutaneous coronary intervention: Insight into contemporary practice in Chinese patients","volume":"18","author":"Wang","year":"2016","journal-title":"Eur Heart J Suppl"},{"key":"R15-1-20210129","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.108.828541","article-title":"Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: The CRUSADE (Can rapid risk stratification of unstable angina patients suppress ADverse outcomes with early implementation of the ACC\/AHA guidelines) bleeding score","volume":"119","author":"Subherwal","year":"2009","journal-title":"Circulation"},{"key":"R16-1-20210129","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the bleeding academic research consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"R17-1-20210129","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/bcp.13436","article-title":"Pharmacodynamics and pharmacokinetics of ticagrelor vs. Clopidogrel in patients with acute coronary syndromes and chronic kidney disease","volume":"84","author":"Wang","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"R18-1-20210129","doi-asserted-by":"crossref","first-page":"478","DOI":"10.5414\/CP202017","article-title":"Pharmacokinetics, pharmacodynamics, and tolerability of single and multiple doses of ticagrelor in Japanese and caucasian volunteers","volume":"52","author":"Teng","year":"2014","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R19-1-20210129","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1160\/TH15-05-0366","article-title":"Influence of platelet reactivity on BARC classification in East Asian patients undergoing percutaneous coronary intervention. Results of the ACCEL-BLEED study","volume":"115","author":"Kwon","year":"2016","journal-title":"Thromb Haemost"},{"key":"R20-1-20210129","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.2016.3775","article-title":"Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention","volume":"315","author":"Yeh","year":"2016","journal-title":"JAMA"},{"key":"R21-1-20210129","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(13)60108-7","article-title":"Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: Development and validation of SYNTAX score II","volume":"381","author":"Farooq","year":"2013","journal-title":"Lancet"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.239306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:48:50Z","timestamp":1623959330000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201809050-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,5]]},"references-count":21,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.239306","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9,5]]}}}